191 related articles for article (PubMed ID: 19502417)
1. Adipose tissue expression and genetic variants of the bone morphogenetic protein receptor 1A gene (BMPR1A) are associated with human obesity.
Böttcher Y; Unbehauen H; Klöting N; Ruschke K; Körner A; Schleinitz D; Tönjes A; Enigk B; Wolf S; Dietrich K; Koriath M; Scholz GH; Tseng YH; Dietrich A; Schön MR; Kiess W; Stumvoll M; Blüher M; Kovacs P
Diabetes; 2009 Sep; 58(9):2119-28. PubMed ID: 19502417
[TBL] [Abstract][Full Text] [Related]
2. Genetic and evolutionary analyses of the human bone morphogenetic protein receptor 2 (BMPR2) in the pathophysiology of obesity.
Schleinitz D; Klöting N; Böttcher Y; Wolf S; Dietrich K; Tönjes A; Breitfeld J; Enigk B; Halbritter J; Körner A; Schön MR; Jenkner J; Tseng YH; Lohmann T; Dressler M; Stumvoll M; Blüher M; Kovacs P
PLoS One; 2011 Feb; 6(2):e16155. PubMed ID: 21311592
[TBL] [Abstract][Full Text] [Related]
3. Role of genetic variation in the cannabinoid type 1 receptor gene (CNR1) in the pathophysiology of human obesity.
Schleinitz D; Carmienke S; Böttcher Y; Tönjes A; Berndt J; Klöting N; Enigk B; Müller I; Dietrich K; Breitfeld J; Scholz GH; Engeli S; Stumvoll M; Blüher M; Kovacs P
Pharmacogenomics; 2010 May; 11(5):693-702. PubMed ID: 20415562
[TBL] [Abstract][Full Text] [Related]
4. Effect of genetic variation in the human fatty acid synthase gene (FASN) on obesity and fat depot-specific mRNA expression.
Schleinitz D; Klöting N; Körner A; Berndt J; Reichenbächer M; Tönjes A; Ruschke K; Böttcher Y; Dietrich K; Enigk B; Filz M; Schön MR; Jenkner J; Kiess W; Stumvoll M; Blüher M; Kovacs P
Obesity (Silver Spring); 2010 Jun; 18(6):1218-25. PubMed ID: 19876008
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans.
Böttcher Y; Teupser D; Enigk B; Berndt J; Klöting N; Schön MR; Thiery J; Blüher M; Stumvoll M; Kovacs P
J Clin Endocrinol Metab; 2006 Jul; 91(7):2725-31. PubMed ID: 16636125
[TBL] [Abstract][Full Text] [Related]
6. Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression.
Kovacs P; Geyer M; Berndt J; Klöting N; Graham TE; Böttcher Y; Enigk B; Tönjes A; Schleinitz D; Schön MR; Kahn BB; Blüher M; Stumvoll M
Diabetes; 2007 Dec; 56(12):3095-100. PubMed ID: 17728376
[TBL] [Abstract][Full Text] [Related]
7. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in the vaspin gene affects circulating serum vaspin concentrations.
Breitfeld J; Tönjes A; Böttcher Y; Schleinitz D; Wiele N; Marzi C; Brockhaus C; Rathmann W; Huth C; Grallert H; Illig T; Blüher M; Kovacs P; Stumvoll M
Int J Obes (Lond); 2013 Jun; 37(6):861-6. PubMed ID: 22907691
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein 2 (BMP2) may contribute to partition of energy storage into visceral and subcutaneous fat depots.
Guiu-Jurado E; Unthan M; Böhler N; Kern M; Landgraf K; Dietrich A; Schleinitz D; Ruschke K; Klöting N; Faßhauer M; Tönjes A; Stumvoll M; Körner A; Kovacs P; Blüher M
Obesity (Silver Spring); 2016 Oct; 24(10):2092-100. PubMed ID: 27515773
[TBL] [Abstract][Full Text] [Related]
10. Paired subcutaneous and visceral adipose tissue aquaporin-7 expression in human obesity and type 2 diabetes: differences and similarities between depots.
Miranda M; Escoté X; Ceperuelo-Mallafré V; Alcaide MJ; Simón I; Vilarrasa N; Wabitsch M; Vendrell J
J Clin Endocrinol Metab; 2010 Jul; 95(7):3470-9. PubMed ID: 20463097
[TBL] [Abstract][Full Text] [Related]
11. TCF7L2 gene expression in human visceral and subcutaneous adipose tissue is differentially regulated but not associated with type 2 diabetes mellitus.
Kovacs P; Berndt J; Ruschke K; Klöting N; Schön MR; Körner A; Stumvoll M; Blüher M
Metabolism; 2008 Sep; 57(9):1227-31. PubMed ID: 18702948
[TBL] [Abstract][Full Text] [Related]
12. The associations of LPIN1 gene expression in adipose tissue with metabolic phenotypes in the Chinese population.
Chang YC; Chang LY; Chang TJ; Jiang YD; Lee KC; Kuo SS; Lee WJ; Chuang LM
Obesity (Silver Spring); 2010 Jan; 18(1):7-12. PubMed ID: 19543209
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous adipose tissue expression of tumour necrosis factor-alpha is not associated with whole body insulin resistance in obese nondiabetic or in type-2 diabetic subjects.
Koistinen HA; Bastard JP; Dusserre E; Ebeling P; Zegari N; Andreelli F; Jardel C; Donner M; Meyer L; Moulin P; Hainque B; Riou JP; Laville M; Koivisto VA; Vidal H
Eur J Clin Invest; 2000 Apr; 30(4):302-10. PubMed ID: 10759878
[TBL] [Abstract][Full Text] [Related]
14. Impact of estrogen receptor gene polymorphisms and mRNA levels on obesity and lipolysis--a cohort study.
Nilsson M; Dahlman I; Jiao H; Gustafsson JA; Arner P; Dahlman-Wright K
BMC Med Genet; 2007 Dec; 8():73. PubMed ID: 18053221
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous and visceral adipose tissue FTO gene expression and adiposity, insulin action, glucose metabolism, and inflammatory adipokines in type 2 diabetes mellitus and in health.
Samaras K; Botelho NK; Chisholm DJ; Lord RV
Obes Surg; 2010 Jan; 20(1):108-13. PubMed ID: 19763711
[TBL] [Abstract][Full Text] [Related]
16. Loss of BMP receptor type 1A in murine adipose tissue attenuates age-related onset of insulin resistance.
Schulz TJ; Graja A; Huang TL; Xue R; An D; Poehle-Kronawitter S; Lynes MD; Tolkachov A; O'Sullivan LE; Hirshman MF; Schupp M; Goodyear LJ; Mishina Y; Tseng YH
Diabetologia; 2016 Aug; 59(8):1769-77. PubMed ID: 27209464
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic and Type 2 diabetic subjects.
Koistinen HA; Dusserre E; Ebeling P; Vallier P; Koivisto VA; Vidal H
Diabetes Metab Res Rev; 2000; 16(5):364-9. PubMed ID: 11025560
[TBL] [Abstract][Full Text] [Related]
18. The FTO obesity gene. Genotyping and gene expression analysis in morbidly obese patients.
Zabena C; González-Sánchez JL; Martínez-Larrad MT; Torres-García A; Alvarez-Fernández-Represa J; Corbatón-Anchuelo A; Pérez-Barba M; Serrano-Ríos M
Obes Surg; 2009 Jan; 19(1):87-95. PubMed ID: 18855084
[TBL] [Abstract][Full Text] [Related]
19. RARRES2, encoding the novel adipokine chemerin, is a genetic determinant of disproportionate regional body fat distribution: a comparative magnetic resonance imaging study.
Müssig K; Staiger H; Machicao F; Thamer C; Machann J; Schick F; Claussen CD; Stefan N; Fritsche A; Häring HU
Metabolism; 2009 Apr; 58(4):519-24. PubMed ID: 19303973
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of insulin receptor substrate-1(IRS-1) in visceral and subcutaneous adipose depots of morbidly obese subjects undergoing bariatric surgery in a tertiary care center in north India; SNP analysis and correlation with metabolic profile.
Sharma M; Aggarwal S; Nayar U; Vikram NK; Misra A; Luthra K
Diabetes Metab Syndr; 2021; 15(3):981-986. PubMed ID: 33975152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
